Abstrakt

Przypisy

• 1. Arunachalam P., Kumar V.R., Swathi D.: Kasabach-Merritt syndromewith large cutaneous vascular tumors. J. Indian Assoc. Pediatr.Surg., 2012; 17: 33-36
  Google Scholar
• 2. Bruckner A.L., Frieden I.J.: Hemangiomas of infancy. J. Am. Acad.Dermatol., 2003; 48: 477-493
  Google Scholar
• 3. Chakkittakandiyil A., Phillips R., Frieden I., Siegfried E., Lara–Corrales I., Lam J., Bergmann J., Bekhor P., Poorsattar S., Pope E.:Timolol maleate 0,5% or 0,1% gel-forming solution for infantile hemangiomas:a retrospective, multicenter, cohort study. Pediatr. Dermatol.,2012; 29: 28-31
  Google Scholar
• 4. Drolet B.A., Scott L.A., Esterly N.B., Gosain A.K.: Early surgicalintervention in a patient with Kasabach-Merritt phenomenon. J.Pediatr., 2001; 138: 756-758
  Google Scholar
• 5. El-Dessouky M., Azmy A., Raine P.A., Young D.G.: Kasabach-Merrittsyndrome. J. Pediatr. Surg., 1988; 23: 109-111
  Google Scholar
• 6. Enomoto Y., Yoshimura S., Egashira Y., Iwama T.: Transarterialembolization of cervical hemangioma associated with Kasabach–Merritt syndrome. Neurol. Med. Chir., 2011; 51: 375-378
  Google Scholar
• 7. Ezekowitz R.A., Mulliken J.B., Folkman J.: Interferon alfa-2a therapyfor life-threatening hemangiomas of infancy. N. Engl. J. Med.,1992; 326: 1456-1463
  Google Scholar
• 8. Frieden I.J., Haggstrom A.N., Drolet B.A., Mancini A.J., FriedlanderS.F., Boon L., Chamlin S.L., Baselga E., Garzon M.C., Nopper A.J.,Siegel D.H., Mathes E.W., Goddard D.S., Bischoff J., North P.E., EsterlyN.B.: Infantile hemangiomas: current knowledge, future directions.Proceedings of a research workshop on infantile hemangiomas. Pediatr.Dermatol., 2005; 22: 383-406
  Google Scholar
• 9. Guo S., Ni N.: Topical treatment for capillary hemangioma ofthe eyelid using beta-blocker solution. Arch. Ophthalmol., 2010;128: 255-256
  Google Scholar
• 10. Haisley-Royster C., Enjolras O., Frieden I.J., Garzon M., Lee M.,Oranje A., de Laat P.C., Madern G.C., Gonzalez F., Frangoul H., LeMoine P., Prose N.S., Adams D.M.: Kasabach-Merritt phenomenon:a retrospective study of treatment with vincristine. J. Pediatr. Hematol.Oncol., 2002; 24: 459-462
  Google Scholar
• 11. Hermans D.J., van Beynum I.M., van der Vijver R.J., Kool L.J.,de Blaauw I., van der Vleuten C.J.: Kaposi form hemangioendotheliomawith Kasabach-Merritt syndrome: a new indicationfor propranolol treatment. J.Pediatr. Hematol. Oncol., 2011; 33:e171-e173
  Google Scholar
• 12. Hesselmann S., Micke O., Marquardt T., Baas S., Bramswig J.H.,Harms E., Willich N.: Kasabach-Merritt syndrome: a review of thetherapeutic options and a case report of successful treatment withradiotherapy and interferon alpha. Br. J. Radiol., 2002; 75: 180-184
  Google Scholar
• 13. Holmes W., Mishra A., Gorst C., Liew S.: Propranolol as first-linetreatment for rapidly proliferating infantile hemangiomas. J. Plast.Reconstr. Aesthet. Surg., 2011; 64: 445-451
  Google Scholar
• 14. Kasabach H.H., Merritt: Capillary hemangioma with extensivepurpura: report of a case. Am. J. Dis. Child., 1940; 59: 1063-1070
  Google Scholar
• 15. Kim T.K., Roh M.R., Cho S., Chung K.Y.: Kasabach-Merritt syndromearising from tufted angioma successfully treated with systemiccorticosteroid. Ann. Dermatol., 2010; 22: 426-430
  Google Scholar
• 16. Leaute-Labreze C., Dumas de la Roque E., Hubiche T., BoraleviF., Thambo J.B., Taieb A.: Propranolol for severe hemangiomas ofinfancy. N. Engl. J. Med., 2008; 358: 2649-2651
  Google Scholar
• 17. Leboulanger N., Fayoux P., Teissier N., Cox A., Van Den AbbeeleT., Carrabin L., Couloigner V., Nicollas R., Triglia J.M., Ayari S., FroehlichP., Lescanne E., Marianowski R., Mom T., Mondain M., MarieJ.P., Roger G., Garabédian E.N., Denoyelle F.: Propranolol in the therapeuticstrategy of infantile laryngotracheal hemangioma: a preliminaryretrospective study of French experience. Int. J. Pediatr.Otorhinolaryngol., 2010; 11: 1254-1257
  Google Scholar
• 18. Maguiness S.M., Frieden I.J.: Current management of infantilehemangiomas. Semin. Cutan. Med. Surg., 2010; 29: 106-114
  Google Scholar
• 19. Manunza F., Syed S., Laguda B., Linward J., Kennedy H., GholamK., Glover M., Giardini A., Harper J.I.: Propranolol for complicatedinfantile haemangiomas: a case series of 30 infants. Br. J. Dermatol.,2010; 162: 466-468
  Google Scholar
• 20. Mendiratta V., Jabeen M.: Infantile hemangioma: an update.Indian J. Dermatol. Venerol. Leprol., 2010; 76: 469-475
  Google Scholar
• 21. Mitsuhashi N., Furuta M., Sakurai H., Takahashi T., Kato S., NozakiM., Saito Y., Hayakawa K., Niibe H.: Outcome of radiation therapyfor patients with Kasabach-Merritt syndrome. Int. J. Radiat. Oncol.Biol. Phys., 1997; 39: 467-473
  Google Scholar
• 22. Oranje A.P., Janmohamed S.R., Madern G.C., de Laat P.C.:Treatment of small superficial haemangioma with timolol 0,5%ophthalmic solution: a series of 20 cases. Dermatology, 2011;223: 330-334
  Google Scholar
• 23. Pope E., Chakkittakandiyil A.: Topical timolol gel for infantilehemangiomas: a pilot study. Arch. Dermatol., 2010; 146: 564-565
  Google Scholar
• 24. Sans V., de la Roque E.D., Berge J., Grenier N., Boralevi F., Mazereeuw-HautierJ., Lipsker D., Dupuis E., Ezzedine K., Vergnes P., TaïebA., Léauté-Labrèze C.: Propranolol for severe infantile hemangiomas:follow-up report. Pediatrics, 2009; 124: e423-e431
  Google Scholar
• 25. Schiestl C., Neuhaus K., Zoller S., Subotic U., Forster-Kuebler I.,Michels R., Balmer C., Weibel L.: Efficacy and safety of propranololas first-line treatment for infantile hemangiomas. Eur. J. Pediatr.,2011; 170: 493-501
  Google Scholar
• 26. Wanankul S., Nuchprayoon I., Seksarn P.: Treatment of Kasabach-Merrittsyndrome: a stepwise regimen of prednisolone, dipyridamole,and interferon. Int. J. Dermatol., 2003; 42: 741-748
  Google Scholar

Pełna treść artykułu